PharmaBlock (USA), Inc. is a subsidiary of PharmaBlock Sciences (Nanjing), Inc., specializing in providing innovative chemistry products and services for pharmaceutical R&D and commercial production. Their core offerings include a collection of building blocks for discovery, development, and commercialization, building block-driven libraries for drug discovery, and the development and manufacturing of RSMs, intermediates, APIs, and drug products. With facilities in the Bay Area of California and the Greater Philadelphia area, equipped with state-of-the-art equipment and an experienced team, PharmaBlock USA focuses on process R&D services, solid state chemistry services, and providing a large collection of high-quality building blocks for drug development and commercial purposes.